Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

MDxHealth (MDXH) FCF Margin (2021 - 2025)

Historic FCF Margin for MDxHealth (MDXH) over the last 5 years, with Q3 2025 value amounting to 8.67%.

  • MDxHealth's FCF Margin rose 165500.0% to 8.67% in Q3 2025 from the same period last year, while for Sep 2025 it was 14.39%, marking a year-over-year increase of 9600.0%. This contributed to the annual value of 28.77% for FY2024, which is 140700.0% up from last year.
  • As of Q3 2025, MDxHealth's FCF Margin stood at 8.67%, which was up 165500.0% from 5.83% recorded in Q2 2025.
  • In the past 5 years, MDxHealth's FCF Margin registered a high of 59.3% during Q1 2023, and its lowest value of 414.12% during Q2 2022.
  • Its 5-year average for FCF Margin is 67.0%, with a median of 32.51% in 2023.
  • Per our database at Business Quant, MDxHealth's FCF Margin skyrocketed by 3082100bps in 2023 and then crashed by -502200bps in 2025.
  • MDxHealth's FCF Margin (Quarter) stood at 116.48% in 2021, then skyrocketed by 40bps to 69.41% in 2022, then soared by 53bps to 32.51% in 2023, then grew by 16bps to 27.45% in 2024, then surged by 68bps to 8.67% in 2025.
  • Its FCF Margin was 8.67% in Q3 2025, compared to 5.83% in Q2 2025 and 16.93% in Q1 2025.